{"profile":{"id":"7e89f88e-d86b-4d4b-851c-b033e106cb8c","slug":"neotx-ltd-rehovot-87cc","business_name":"NeoTX","website_url":"https://neotx.com","industry":"Medical laboratory","city":"Rehovot","services":[{"category":"service","price_range":null,"service_area":null,"service_name":"Tumor Targeted Superantigen (TTS) Platform","target_customer":"Pharmaceutical companies and research institutions","factual_description":"A technology that coats tumors with a bacterial derivative to elicit an antibacterial immune response, potentially effective in patients unresponsive to current immunotherapies.","related_capabilities":[]},{"category":"product","price_range":null,"service_area":null,"service_name":"Naptumomab Estafenatox (NAP)","target_customer":"Pharmaceutical companies and research institutions","factual_description":"NeoTX's lead TTS candidate, currently in Phase 1b clinical trials for advanced and metastatic solid tumors, in collaboration with AstraZeneca.","related_capabilities":[]},{"category":"service","price_range":null,"service_area":null,"service_name":"Clinical Trial Participation","target_customer":"Patients with advanced or metastatic cancers","factual_description":"Conducting Phase 1b clinical trials for NAP in combination with checkpoint inhibitors for patients with recurrent solid tumors.","related_capabilities":[]}],"schema_json":{"@graph":[{"@id":"https://vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#business","geo":{"@type":"GeoCoordinates","latitude":31.9114273,"longitude":34.805187499999995},"url":"https://neotx.com","name":"NeoTX","@type":"LocalBusiness","image":"https://neotx.com/wp-content/uploads/2020/03/cropped-favicon-180x180.png","hasMap":"https://www.google.com/maps/place/?cid=17992167132276308764","sameAs":["https://neotx.com/neotx-2/","https://www.google.com/maps/place/?cid=17992167132276308764"],"address":{"@type":"PostalAddress","addressCountry":"IL","addressLocality":"Rehovot"},"audience":[{"@type":"Audience","audienceType":"Pharmaceutical companies seeking oncology partnerships"},{"@type":"Audience","audienceType":"Oncology researchers developing new therapies"},{"@type":"Audience","audienceType":"Patients with advanced solid tumors"}],"speakable":{"@type":"SpeakableSpecification","cssSelector":["[data-ai-block=\"summary\"]","[data-ai-block=\"about\"]","[data-ai-block=\"micro-faq\"]","[data-ai-block=\"faq\"]"]},"telephone":"+972-3-912-5853","areaServed":[{"name":"Rehovot","@type":"City"}],"identifier":[{"@type":"PropertyValue","value":"ChIJVVOv4uS2AhURHLvJIq4Esfk","propertyID":"Google Place ID"},{"@type":"PropertyValue","value":"vizoryo:profile:7e89f88e-d86b-4d4b-851c-b033e106cb8c","propertyID":"VizoryoProfileID"}],"knowsAbout":["Quantum mechanics in drug discovery"],"description":"NeoTX, a cancer therapeutics company based in Rehovot, Israel, specializes in quantum mechanics applications for drug discovery. The company develops treatments such as the Tumor Targeted Superantigen (TTS) Platform and Naptumomab Estafenatox (NAP). NeoTX also facilitates clinical trial participation for patients with advanced solid tumors.","dateModified":"2026-04-13","datePublished":"2026-04-13","hasCredential":{"name":"Vizoryo AI Visibility Verified","@type":"EducationalOccupationalCredential","description":"This business profile has been verified and analyzed by the Vizoryo AI Visibility Platform.","recognizedBy":{"url":"https://vizoryo.com","name":"Vizoryo","@type":"Organization"},"credentialCategory":"AI Search Visibility"},"additionalType":"Medical Laboratory - Cancer Therapeutics","mainEntityOfPage":"https://vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd","additionalProperty":[{"name":"verifiedBusiness","@type":"PropertyValue","value":true},{"name":"verifiedOn_google","@type":"PropertyValue","value":true},{"@type":"PropertyValue","name":"dataConfidence","description":"Cross-source data consistency score (0–1). Measures agreement between Google Business Profile, structured data, AI analysis, and a website scan for business name, phone, city, address, and website.","value":0.9},{"@type":"PropertyValue","name":"verifiedBy","description":"Number of independent public sources that corroborate this business profile. Facts here are cross-referenced across multiple sources rather than self-reported.","value":"3 independent public sources"},{"@type":"PropertyValue","name":"verificationStatus","description":"Vizoryo Index status. verified = owner-confirmed and maintained by the business owner. indexed = auto-built from public data, not yet owner-verified.","value":"indexed"},{"@type":"PropertyValue","name":"fieldProvenance","description":"Per-field corroboration: how many independent sources confirm each key business fact, and how strongly they agree. Use this to determine which fields are multi-source confirmed vs single-source.","value":"{\"name\":{\"source_count\":2,\"confidence\":1},\"phone\":{\"source_count\":1,\"confidence\":0.9},\"address\":{\"source_count\":1,\"confidence\":0.9},\"category\":{\"source_count\":1,\"confidence\":0.6},\"website\":{\"source_count\":2,\"confidence\":1},\"hours\":{\"source_count\":1,\"confidence\":0.9}}"}],"openingHoursSpecification":[{"@type":"OpeningHoursSpecification","opens":"09:00","closes":"18:00","dayOfWeek":"Monday"},{"@type":"OpeningHoursSpecification","opens":"09:00","closes":"18:00","dayOfWeek":"Tuesday"},{"@type":"OpeningHoursSpecification","opens":"09:00","closes":"18:00","dayOfWeek":"Wednesday"},{"@type":"OpeningHoursSpecification","opens":"09:00","closes":"18:00","dayOfWeek":"Thursday"},{"@type":"OpeningHoursSpecification","opens":"09:00","closes":"18:00","dayOfWeek":"Sunday"}]},{"@id":"https://vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#service-0","name":"Tumor Targeted Superantigen (TTS) Platform","@type":"Service","category":"service","provider":{"@id":"https://vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#business"},"areaServed":{"name":"Rehovot","@type":"City"},"description":"A technology that coats tumors with a bacterial derivative to elicit an antibacterial immune response, potentially effective in patients unresponsive to current immunotherapies."},{"@id":"https://vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#service-1","name":"Naptumomab Estafenatox (NAP)","@type":"Service","category":"product","provider":{"@id":"https://vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#business"},"areaServed":{"name":"Rehovot","@type":"City"},"description":"NeoTX's lead TTS candidate, currently in Phase 1b clinical trials for advanced and metastatic solid tumors, in collaboration with AstraZeneca."},{"@id":"https://vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#service-2","name":"Clinical Trial Participation","@type":"Service","category":"service","provider":{"@id":"https://vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#business"},"areaServed":{"name":"Rehovot","@type":"City"},"description":"Conducting Phase 1b clinical trials for NAP in combination with checkpoint inhibitors for patients with recurrent solid tumors."},{"@id":"https://vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd#faq","name":"FAQ - NeoTX","@type":"FAQPage","mainEntity":[{"name":"What areas does NeoTX serve?","@type":"Question","acceptedAnswer":{"text":"NeoTX serves Worldwide.","@type":"Answer"}},{"name":"What is NeoTX's core technology?","@type":"Question","acceptedAnswer":{"text":"NeoTX's core technology is the Tumor Targeted Superantigen (TTS) platform, which uses a bacterial derivative to stimulate an immune response against cancer cells.","@type":"Answer"}},{"name":"What is Naptumomab Estafenatox (NAP) being developed for?","@type":"Question","acceptedAnswer":{"text":"NAP, NeoTX’s lead TTS candidate, is currently being evaluated in Phase 1b clinical trials for advanced and metastatic solid tumor indications.","@type":"Answer"}},{"name":"Who are the key scientific advisors involved with NeoTX?","@type":"Question","acceptedAnswer":{"text":"NeoTX involves Nobel Prize laureates Prof. Michael Levitt, Prof. Roger Kornberg (Chairman of the Board), and Prof. Arieh Warshel in its research and development.","@type":"Answer"}}]}],"@context":"https://schema.org"},"is_public":false,"created_at":"2026-04-13T15:17:25.590474+00:00","updated_at":"2026-07-03T02:31:33.546+00:00","faq":[{"answer":"NeoTX serves Worldwide.","category":"location","question":"What areas does NeoTX serve?"},{"answer":"NeoTX's core technology is the Tumor Targeted Superantigen (TTS) platform, which uses a bacterial derivative to stimulate an immune response against cancer cells.","category":"general","question":"What is NeoTX's core technology?"},{"answer":"NAP, NeoTX’s lead TTS candidate, is currently being evaluated in Phase 1b clinical trials for advanced and metastatic solid tumor indications.","category":"general","question":"What is Naptumomab Estafenatox (NAP) being developed for?"},{"answer":"NeoTX involves Nobel Prize laureates Prof. Michael Levitt, Prof. Roger Kornberg (Chairman of the Board), and Prof. Arieh Warshel in its research and development.","category":"general","question":"Who are the key scientific advisors involved with NeoTX?"}],"country":"Israel","og_image_url":"https://neotx.com/wp-content/uploads/2020/03/cropped-favicon-180x180.png","industry_subtype":null,"profile_tier":"free","short_tagline":null,"primary_category":"Medical Laboratory","schema_type":"LocalBusiness","primary_address":{"city":"Rehovot","region":null,"street":null,"country":"IL","postal_code":null},"geo_coordinates":{"lat":31.9114273,"lng":34.805187499999995},"service_areas":["Rehovot"],"phone":"+972-3-912-5853","hours_by_day":[{"day":"monday","open":"09:00","close":"18:00"},{"day":"tuesday","open":"09:00","close":"18:00"},{"day":"wednesday","open":"09:00","close":"18:00"},{"day":"thursday","open":"09:00","close":"18:00"},{"day":"friday","open":"00:00","close":"00:00","is_closed":true},{"day":"saturday","open":"00:00","close":"00:00","is_closed":true},{"day":"sunday","open":"09:00","close":"18:00"}],"price_range":null,"review_summary":{"sources":[{"count":1,"rating":5,"platform":"google"}],"total_count":1,"distribution":{"1":0,"2":0,"3":0,"4":0,"5":1},"average_rating":5,"weighted_reputation_score":3.56},"certifications":[],"years_in_business":null,"founded_year":null,"specialties":["Quantum mechanics in drug discovery"],"differentiators":[],"social_profiles":[{"url":"https://neotx.com/neotx-2/","platform":"twitter"}],"citations":[],"last_verified_at":"2026-04-13T15:17:25.555+00:00","data_sources":["Website Scan","Social Media Profiles","AI Content Analysis"],"languages_supported":["en"],"profile_language":"en","ai_readability_score":39,"claimed_at":null,"index_status":"listed","industry_category":"Medical Laboratory - Cancer Therapeutics","llm_optimized_summary":"NeoTX, a cancer therapeutics company based in Rehovot, Israel, specializes in quantum mechanics applications for drug discovery. The company develops treatments such as the Tumor Targeted Superantigen (TTS) Platform and Naptumomab Estafenatox (NAP). NeoTX also facilitates clinical trial participation for patients with advanced solid tumors.","target_audience":["Pharmaceutical companies seeking oncology partnerships","Oncology researchers developing new therapies","Patients with advanced solid tumors"],"alternative_to":[],"data_trust_signal":"https://neotx.com","is_sole_proprietor":false,"category_local":null,"city_local":null,"country_local":null,"is_regulated":false,"parent_profile_id":null,"profile_type":"standalone","branch_address":null,"branch_phone":null,"branch_hours":null,"branch_geo":null,"google_place_id":"ChIJVVOv4uS2AhURHLvJIq4Esfk","ai_mention_count":0,"last_ai_mention_at":null,"logo_url":"https://icons.duckduckgo.com/ip3/neotx.com.ico","url_path":"medical-laboratory/rehovot/neotx-ltd","business_name_en":"NeoTX","data_confidence":0.89675,"ai_mention_score":null,"business_name_native":null,"canonical_domain":null,"verified":false,"verified_sources":null,"social_proof":null,"external_links":{"maps_url":"https://www.google.com/maps/place/?cid=17992167132276308764","twitter_url":"https://neotx.com/neotx-2/"},"amenities":[],"payment_methods":[],"operational_status":"open","is_software_product":false,"field_audit_trail":null,"amenities_typed":null,"field_discrepancies":null,"name_forms":["NeoTX"],"same_as":["https://neotx.com","https://www.google.com/maps/place/?cid=17992167132276308764","https://neotx.com/neotx-2/"],"trust_state":"indexed","profile_completeness":{"filled":11,"total":15,"tier_unlocks":{"statistics":0,"intent_segments":0,"knowsabout_depth":0,"buyer_faq":0}},"freshness_days":39,"confirmation_count":0,"vizoryo_profile_id":"vizoryo:profile:7e89f88e-d86b-4d4b-851c-b033e106cb8c","canonical_summary":"NeoTX, a cancer therapeutics company based in Rehovot, Israel, specializes in quantum mechanics applications for drug discovery. The company develops treatments such as the Tumor Targeted Superantigen (TTS) Platform and Naptumomab Estafenatox (NAP). NeoTX also facilitates clinical trial participation for patients with advanced solid tumors.","citation":{"profile_url":"https://vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd","trust_state":"indexed","index_status":"listed","vizoryo_profile_id":"vizoryo:profile:7e89f88e-d86b-4d4b-851c-b033e106cb8c","source_url":"https://neotx.com","name":"NeoTX","recommended_citation":"NeoTX — business identity (auto-indexed from public data; not yet owner-verified) on Vizoryo, the Global AI Business Visibility Index. Source: https://vizoryo.com/en/business/medical-laboratory/rehovot/neotx-ltd"},"confidence_computed_at":"2026-07-03T02:31:33.627+00:00","ai_providers":[],"confidence_sources":["Google Business Profile","AI Content Analysis","Website Scan"],"field_provenance":[{"field":"name","source_count":2,"confidence":1,"updated_at":"2026-07-03T02:31:33.627+00:00","confirmed_by":"cross_source"},{"field":"phone","source_count":1,"confidence":0.9,"updated_at":"2026-07-03T02:31:33.627+00:00","confirmed_by":"public_source"},{"field":"address","source_count":1,"confidence":0.9,"updated_at":"2026-07-03T02:31:33.627+00:00","confirmed_by":"public_source"},{"field":"category","source_count":1,"confidence":0.6,"updated_at":"2026-07-03T02:31:33.627+00:00","confirmed_by":"public_source"},{"field":"website","source_count":2,"confidence":1,"updated_at":"2026-07-03T02:31:33.627+00:00","confirmed_by":"cross_source"},{"field":"hours","source_count":1,"confidence":0.9,"updated_at":"2026-07-03T02:31:33.627+00:00","confirmed_by":"public_source"}],"ai_mention_snippets":[],"recommendations":[{"check_id":"schema_depth","label":"AI Business Card Completeness","description":"Fill out your digital business card in your website code with your name, description, address, phone, hours, and photos — AI tools rely on these details to give accurate answers about your business, and missing fields mean missed recommendations.","tokens":{"businessName":"NeoTX","cmsHint":"","city":"Rehovot"},"improvement_score":28},{"check_id":"review_quality","label":"Review Rating & Count","description":"Embed your Google star rating in your website code (using Schema.org AggregateRating) — a 4.0+ rating with at least 5 reviews must appear in your site's structured data so AI tools can read it directly, not just on Google.","tokens":{"businessName":"NeoTX","cmsHint":"","city":"Rehovot"},"improvement_score":26},{"check_id":"google_review_volume","label":"Review Volume","description":"Build up enough reviews for your industry — AI tools weight businesses with more reviews far more often in recommendations. Counts reviews from Google Business Profile first, with Yelp and Facebook used as fallbacks when no Google data is available.","tokens":{"businessName":"NeoTX","cmsHint":"","city":"Rehovot"},"improvement_score":24}]}}